What is the Syncom Formulations (India) Ltd share price today?

The share price of NSE:SYNCOMF-EQ on 01 Oct 2026 (as of 15:05:02 IST) is ₹24.

What is the NSE:SYNCOMF-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SYNCOMF-EQ 52 week high low range shows a high of ₹27.49 and a low of ₹10.21.

What is the Syncom Formulations (India) Ltd market cap?

As on 01 Oct 2026, Syncom Formulations (India) Ltd market cap is ₹23706800000.

What is the shareholding pattern of Syncom Formulations (India) Ltd Stock?

The shareholding pattern of Syncom Formulations (India) Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 50.57% Foreign Institutional Investors (FII): 0.35% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 49.08% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Syncom Formulations (India) Ltd?

The Price-to-Earnings (PE) ratio of Syncom Formulations (India) Ltd is 27.7175, and the Price-to-Book (PB) ratio is 2.3331, as on 01 Oct 2026.

Syncom Formulations (India) Share Price

20.43+1.36 (+7.13%)

+22.85% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+7.13%

1 Week

+6.19%

1 Month

-11.71%

3 Month

+55.01%

6 Month

+39.26%

YTD

+43.27%

1 Year

+22.85%

5 Year

10 Year

Max

+133.49%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

18.95

18.88

13.11

12.79

10.21

High

20.57

25.49

27.49

About

Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations. The company manufactures range of products in various dosage forms and markets them in various countries. In addition Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

SYNCOMFNSE

LTP

1W Low

1W High

Market cap (₹)

1794.9+17.2 (0.97%)

1722

1796.60

4,25,150Cr

9953.5+173.5 (1.77%)

9863

10067

2,66,265Cr

4649.7+36.3 (0.79%)

4553

4675

1,76,301Cr

2318.7-86.8 (-3.61%)

2252.40

2441.90

1,25,352Cr

1257.3+11.8 (0.95%)

1217.20

1264.50

1,23,591Cr

1367.7+15.7 (1.16%)

1336.70

1376.70

1,14,351Cr

1394.5+15.6 (1.13%)

1364.60

1400.80

1,12,474Cr

2490.4-2.4 (-0.10%)

2457.90

2512.30

1,02,315Cr

1698.4+17 (1.01%)

1656.20

1708.80

97,757Cr

2016.5+5.5 (0.27%)

1988.90

2062.10

92,007Cr

20.43+1.19 (6.19%)

18.88

20.57

1,794Cr

Syncom Formulations (India) Share Price

20.43+1.36 (+7.13%)

+22.85% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Syncom Formulations (India) Share Price

20.43+1.36 (+7.13%)

+22.85% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years21%

3 years30%

Last year5%

Compounded Profit Growth

10 years-

5 years49%

3 years56%

Last year55%

Stock Price CAGR

10 years-

5 years-

3 years29%

1 year15%

Return on Equity

10 years11%

5 years13%

3 years15%

Last year20%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	21%	30%	5%
-	49%	56%	55%
-	-	29%	15%
11%	13%	15%	20%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

SYNCOMF

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,794.9	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
9,953.5	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,649.9	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,318.7	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,257.3	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,367.7	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,394.5	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,490.4	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,698.4	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,016.5	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
20.43	₹1794 Cr	20.98	0.26	0.98	₹76 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Dec 2013	Mar 2013	Dec 2012	Mar 2012
₹126 Cr	₹135 Cr	₹115 Cr	₹122 Cr	₹117 Cr	₹149 Cr	₹128 Cr	₹102 Cr	₹87 Cr	₹75 Cr	₹65 Cr	₹64 Cr	₹60 Cr	₹61 Cr	₹57 Cr	₹54 Cr	₹51 Cr	₹58 Cr	₹57 Cr	₹53 Cr	₹41 Cr	₹35 Cr	₹34 Cr	₹27 Cr
₹8 Cr	₹15 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹1 Cr	₹3 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹7 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹6 Cr	₹2 Cr	₹3 Cr	₹25 L	₹49 L	₹40 L	₹53 L
₹133 Cr	₹150 Cr	₹121 Cr	₹127 Cr	₹123 Cr	₹156 Cr	₹132 Cr	₹106 Cr	₹89 Cr	₹78 Cr	₹70 Cr	₹68 Cr	₹62 Cr	₹68 Cr	₹59 Cr	₹57 Cr	₹54 Cr	₹64 Cr	₹59 Cr	₹56 Cr	₹41 Cr	₹35 Cr	₹35 Cr	₹27 Cr
₹101 Cr	₹116 Cr	₹95 Cr	₹105 Cr	₹102 Cr	₹132 Cr	₹114 Cr	₹91 Cr	₹78 Cr	₹66 Cr	₹59 Cr	₹58 Cr	₹54 Cr	₹56 Cr	₹53 Cr	₹51 Cr	₹49 Cr	₹57 Cr	₹53 Cr	₹48 Cr	₹37 Cr	₹33 Cr	₹31 Cr	₹27 Cr
₹34 Cr	₹37 Cr	₹27 Cr	₹24 Cr	₹22 Cr	₹25 Cr	₹19 Cr	₹16 Cr	₹12 Cr	₹13 Cr	₹12 Cr	₹10 Cr	₹8 Cr	₹13 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹1 Cr
₹25 L	₹38 L	₹26 L	₹27 L	₹25 L	₹12 L	₹20 L	₹16 L	₹39 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹72 L	₹62 L	₹50 L	₹1 Cr	₹15 L	₹12 L	₹2 L	₹9 L	₹11 L	₹15 L
₹32 Cr	₹34 Cr	₹25 Cr	₹22 Cr	₹20 Cr	₹23 Cr	₹17 Cr	₹15 Cr	₹10 Cr	₹10 Cr	₹9 Cr	₹8 Cr	₹6 Cr	₹10 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹20 L
₹25 Cr	₹25 Cr	₹19 Cr	₹17 Cr	₹16 Cr	₹18 Cr	₹13 Cr	₹11 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹4 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹2 Cr	-₹85 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
—	—	—	—	—	—	—	—	—	—
₹94 Cr	₹94 Cr	₹94 Cr	₹94 Cr	₹86 Cr	₹78 Cr	₹78 Cr	₹78 Cr	₹78 Cr	₹22 Cr
₹0	₹0	₹0	₹0	₹5 Cr	₹0	₹0	₹0	₹0	₹0
₹321 Cr	₹248 Cr	₹194 Cr	₹162 Cr	₹131 Cr	₹39 Cr	₹31 Cr	₹22 Cr	₹17 Cr	₹65 Cr
₹321 Cr	₹248 Cr	₹194 Cr	₹162 Cr	₹131 Cr	₹39 Cr	₹31 Cr	₹22 Cr	₹17 Cr	₹65 Cr
₹415 Cr	₹342 Cr	₹288 Cr	₹256 Cr	₹222 Cr	₹117 Cr	₹109 Cr	₹100 Cr	₹95 Cr	₹88 Cr
₹8 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹6 Cr
₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹58 L	₹42 L	₹17 L	₹12 L	₹2 Cr
₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0
₹15 Cr	₹12 Cr	₹10 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹8 Cr
—	—	—	—	—	—	—	—	—	—
₹74 Cr	₹44 Cr	₹24 Cr	₹20 Cr	₹14 Cr	₹32 Cr	₹47 Cr	₹20 Cr	₹29 Cr	₹19 Cr
₹21 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹3 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹86 L	₹2 Cr
₹1 Cr	₹5 Cr	₹72 Cr	₹83 Cr	₹58 Cr	₹12 Cr	₹6 Cr	₹6 Cr	₹3 Cr	₹2 Cr
₹9 Cr	₹6 Cr	₹6 Cr	₹3 Cr	₹4 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹5 Cr
₹106 Cr	₹62 Cr	₹109 Cr	₹113 Cr	₹78 Cr	₹59 Cr	₹66 Cr	₹37 Cr	₹42 Cr	₹28 Cr
₹536 Cr	₹416 Cr	₹407 Cr	₹378 Cr	₹308 Cr	₹184 Cr	₹181 Cr	₹143 Cr	₹144 Cr	₹124 Cr
₹78 L	₹86 L	₹55 L	₹55 L	₹55 L	₹3 Cr	₹83 L	₹83 L	₹82 L	₹2 Cr
₹1 Cr	₹5 Cr	₹72 Cr	₹83 Cr	₹58 Cr	₹12 Cr	₹6 Cr	₹6 Cr	₹3 Cr	₹2 Cr
—	—	—	—	—	—	—	—	—	—
₹157 Cr	₹146 Cr	₹136 Cr	₹102 Cr	₹101 Cr	₹92 Cr	₹82 Cr	₹80 Cr	₹77 Cr	₹74 Cr
₹67 Cr	₹68 Cr	₹63 Cr	₹59 Cr	₹54 Cr	₹37 Cr	₹37 Cr	₹35 Cr	₹27 Cr	₹24 Cr
₹90 Cr	₹78 Cr	₹72 Cr	₹43 Cr	₹47 Cr	₹55 Cr	₹46 Cr	₹46 Cr	₹50 Cr	₹50 Cr
₹0	₹0	₹0	₹26 Cr	₹6 Cr	₹25 L	₹5 Cr	₹0	₹0	₹0
₹3 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹36 Cr	₹23 Cr	₹6 Cr	₹9 Cr	₹7 Cr
₹3 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹36 Cr	₹23 Cr	₹6 Cr	₹9 Cr	₹7 Cr
₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹6 Cr	₹15 Cr	₹7 Cr	₹6 Cr	₹5 Cr
₹16 Cr	₹14 Cr	₹7 Cr	₹76 Cr	₹64 Cr	₹0	₹0	₹0	₹0	₹0
₹203 Cr	₹143 Cr	₹130 Cr	₹196 Cr	₹168 Cr	₹97 Cr	₹89 Cr	₹59 Cr	₹66 Cr	₹62 Cr
—	—	—	—	—	—	—	—	—	—
₹107 Cr	₹89 Cr	₹64 Cr	₹62 Cr	₹41 Cr	₹0	₹0	₹0	₹0	₹0
₹63 Cr	₹41 Cr	₹21 Cr	₹21 Cr	₹20 Cr	₹10 Cr	₹15 Cr	₹11 Cr	₹10 Cr	₹6 Cr
₹111 Cr	₹108 Cr	₹103 Cr	₹76 Cr	₹68 Cr	₹46 Cr	₹46 Cr	₹31 Cr	₹29 Cr	₹29 Cr
₹6 Cr	₹71 L	₹68 Cr	₹9 Cr	₹39 L	₹7 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr
₹7 Cr	₹3 Cr	₹1 Cr	₹4 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹9 Cr	₹6 Cr	₹6 Cr
₹39 Cr	₹30 Cr	₹20 Cr	₹10 Cr	₹8 Cr	₹18 Cr	₹18 Cr	₹25 Cr	₹28 Cr	₹17 Cr
₹333 Cr	₹272 Cr	₹277 Cr	₹182 Cr	₹140 Cr	₹87 Cr	₹92 Cr	₹84 Cr	₹78 Cr	₹62 Cr
₹227 Cr	₹211 Cr	₹168 Cr	₹69 Cr	₹62 Cr	₹28 Cr	₹26 Cr	₹47 Cr	₹36 Cr	₹33 Cr
₹536 Cr	₹416 Cr	₹407 Cr	₹378 Cr	₹308 Cr	₹184 Cr	₹181 Cr	₹143 Cr	₹144 Cr	₹124 Cr
₹4	₹4	₹3	₹3	₹3	₹2	₹1	₹1	₹1	₹39
₹4	₹4	₹3	₹3	₹3	₹2	₹1	₹1	₹1	₹1

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
₹101 Cr	₹66 Cr	₹34 Cr	₹27 Cr	₹26 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹14 Cr	₹8 Cr
-₹30 Cr	-₹11 Cr	-₹3 Cr	-₹6 Cr	-₹7 Cr	₹71 L	₹1 Cr	₹3 Cr	₹2 Cr	₹2 Cr
₹10 Cr	-₹16 Cr	-₹28 Cr	-₹3 Cr	₹4 Cr	₹1 Cr	₹12 Cr	-₹12 Cr	-₹6 Cr	-₹3 Cr
₹81 Cr	₹38 Cr	₹2 Cr	₹17 Cr	₹23 Cr	₹18 Cr	₹30 Cr	₹7 Cr	₹11 Cr	₹8 Cr
₹58 Cr	₹23 Cr	-₹6 Cr	₹11 Cr	₹16 Cr	₹14 Cr	₹24 Cr	₹19 L	₹7 Cr	₹6 Cr
-₹51 Cr	-₹18 Cr	₹83 Cr	-₹45 Cr	-₹27 Cr	-₹18 Cr	-₹23 Cr	₹63 L	-₹4 Cr	-₹32 L
-₹3 Cr	-₹68 Cr	-₹15 Cr	₹35 Cr	₹8 Cr	₹5 Cr	-₹2 Cr	₹68 L	-₹93 L	-₹6 Cr
₹4 Cr	-₹63 Cr	₹63 Cr	₹58 L	-₹2 Cr	₹83 L	-₹1 Cr	₹1 Cr	₹2 Cr	-₹92 L
₹71 L	₹63 Cr	₹88 L	₹30 L	₹3 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹5 Cr
₹5 Cr	₹71 L	₹63 Cr	₹88 L	₹30 L	₹7 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹4 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Syncom Formulations (India) Share Price

20.43+1.36 (+7.13%)

+22.85% past 1 Year

Shareholding summary

Promoters

50.57%

FII

2.23%

DII

Others

47.2%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
50.57%	50.57%	50.57%	50.57%	50.57%	50.57%
2.23%	0.35%	0.21%	0.26%	0.10%	0.41%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
47.20%	49.08%	49.22%	49.17%	49.33%	49.02%

Bulk & block deals

Name

Hrti Private Limited

Alphagrep Securities Private Limited

Qe Securities Llp

Alphagrep Securities Private Limited

Hrti Private Limited

Alphagrep Securities Private Limited

Microcurves Trading Private Limited

Hrti Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Sep 2026	Sell	14 Cr	₹25.39	55.13 L	Bulk	0.586509	NSE
30 Sep 2026	Sell	13.63 Cr	₹25.41	53.65 L	Bulk	0.570779	NSE
30 Sep 2026	Purchase	14.26 Cr	₹25.40	56.15 L	Bulk	0.597301	NSE
30 Sep 2026	Sell	13.80 Cr	₹25.51	54.08 L	Bulk	0.575333	NSE
30 Sep 2026	Purchase	13.59 Cr	₹25.33	53.65 L	Bulk	0.570779	NSE
30 Sep 2026	Purchase	12.60 Cr	₹25.30	49.81 L	Bulk	0.529929	NSE
29 Sep 2026	Purchase	27.92 Cr	₹24.54	1.14 Cr	Bulk	1.210416	NSE
29 Sep 2026	Purchase	18.92 Cr	₹24.94	75.85 L	Bulk	0.806909	NSE
29 Sep 2026	Purchase	11.35 Cr	₹24.70	45.93 L	Bulk	0.488634	NSE
29 Sep 2026	Sell	11.82 Cr	₹24.55	48.15 L	Bulk	0.512213	NSE

Insider trading & SAST

Client name

Shankarlal Bankda Huf

Kedarmal Shankarlal Bankda

Vijay Shankarlal Bankda & Pacs

Asha Bankda

Vimla Bankda

Kedarmal Shankarlal Bankda

Asha Vijay Bankda

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
16 Jun 2023	Promoter Group	Disposal	0.290582	0	0	—	27.31 L	15 Jun 2023	Off Market	0	Insider Trading	—	Equity Shares
16 Jun 2023	Promoter & Director	Acquisition	0.290582	12.44	0	—	27.31 L	15 Jun 2023	Off Market	11,69,26,120	Insider Trading	—	Equity Shares
10 Jun 2022	Promoter	Acquisition	1.44	27.77	0	—	1.35 Cr	28 May 2022	Pref. Allotment	26,09,91,699	SAST	29(2)	—
09 Jun 2022	Promoter Group	Acquisition	1.565303	4.9	3.42 Cr	₹2.53	1.35 Cr	28 May 2022	Conversion of security	4,60,54,319	Insider Trading	—	Equity Shares
09 Jun 2022	Promoter Group	Acquisition	4.643383	4.26	10.13 Cr	₹2.53	4 Cr	28 May 2022	Conversion of security	4,00,59,320	Insider Trading	—	Equity Shares
09 Jun 2022	Promoter	Acquisition	2.78276	12.15	6.07 Cr	₹2.53	2.40 Cr	28 May 2022	Conversion of security	11,41,94,650	Insider Trading	—	Equity Shares
28 Feb 2022	Promoter Group	Acquisition	3.915884	3.77	8.22 Cr	₹2.53	3.25 Cr	25 Feb 2022	Conversion of security	3,25,54,319	Insider Trading	—	Equity Shares

Syncom Formulations (India) Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Syncom Formulations (India) Share Price

Syncom Formulations (India) Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Syncom Formulations (India) Share Price

Syncom Formulations (India) Share Price

Oscillators

Moving averages

Syncom Formulations (India) Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Syncom Formulations (India) Share Price

Corporate Actions

Company details

Syncom Formulations (India) Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Syncom Formulations (India) Share Price

News

Syncom Formulations Q4 FY Results: Net profit rises despite lower revenue

Syncom Formulations Q3 FY26 Results: Net Profit Growth Amid Revenue Decline

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations reports Profit after tax of 15.73 Crores, in the June 2025 quarter

Syncom Formulations (India) informs about certificate

Syncom Formulations (India) informs about disclosure

Syncom Formulations reports Profit after tax of 6.42 Crores, in the December 2023 quarter

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations reports Profit after tax of 6.21 Crores, in the September 2023 quarter

Syncom Formulations (India) informs about annual general meeting

Syncom Formulations reports Profit after tax of 4.25 Crores, in the June 2023 quarter

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations reports Profit after tax of 8.47 Crores, in the March 2023 quarter

Syncom Formulations - Quaterly Results

Syncom Formulations - Quaterly Results

Syncom Formulations (India) Ltd Share Price Today

Syncom Formulations (India) Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator